EP2528946
Aðferðir við meðferð á sjálfsónæmissjúkdómum með DLL4 mótlyfjum
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
28.1.2011EP published:
16.11.2016EP application number:
11701933.1
EP translation filed:
23.11.2016Grant published:
15.12.2016EPO information:
European Patent Register
Max expiry date:
27.1.2031Expiry date:
27.1.2019
Title:
METHODS OF TREATING AUTOIMMUNE DISEASES WITH DLL4 ANTAGONISTS
Timeline
Today
28.1.2011EP application
16.11.2016EP Publication
23.11.2016Translation submitted
15.12.2016Registration published
27.1.2019Expires
Owner
Name:
REGENERON PHARMACEUTICALS, INC.Address:
777 Old Saw Mill River Road, 10591, Tarrytown, NY, US
Inventor
Name:
SKOKOS, DimitrisAddress:
Tarrytown, NY, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
388697 PDate:
1.10.2010Country:
US
Number:
361687 PDate:
6.7.2010Country:
US
Number:
299801 PDate:
29.1.2010Country:
US
Classification
Categories:
C07K 16/22, A61K 39/395, A61P 37/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 19.12.2016
Expires: 27.1.2018
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 8
Paid: 20.12.2017
Expires: 27.1.2019
Payer: PATICE, Ólafur Ragnarsson, hrl.